Advertisement
News
Advertisement

Caliper and Seegene Partner to Provide Innovative Multiplex Molecular Diagnostics Products

Wed, 01/12/2011 - 3:34am
Bio-Medicine.Org

HOPKINTON, Mass. and SEOUL, Korea, Jan. 12, 2011 /PRNewswire/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP) and Seegene, Inc. (KOSDAQ: A096530) today announced that they have entered into a strategic partnership to enable Seegene's SeePlex™ multiplex diagnostic assays to run on Caliper's innovative LabChip® Dx platform. The SeePlex assays will be marketed and distributed outside of the United States in a preferred partnership for use with the LabChip Dx through Seegene's extensive network of global distributors. The parties will co-market Caliper's LabChip Dx platform and Seegene's complete line of unique multiplex diagnostic content effective immediately, and work together to implement specific content and platform technology development efforts to expand the number of diagnostic tests available, which will be offered in a unique, co-branded product brochure. Seegene and Caliper intend to work together to commercialize selected diagnostic assays with improved sensitivity and specificity while reducing overall costs.  

The LabChip Dx system, which includes specific diagnostic identification, scoring and reporting software, developed in collaboration with Seegene, is based on the same approach that has become the standard, microfluidic based, electrophoretic separation platform in life sciences research, enabling high throughput, multiplex, cost effective sample processing for discovery and validation of molecular and companion diagnostics.  The platform can analyze large numbers of multiplex samples using very minimal volume of sample with automatic pipetting and avoids the need to further purify or dilute diagnostic PCR products.  The cost-effective approach of Caliper's robust microfluidics technology explains its high rate of adoption among research laboratories around the world.  

Seegene's proprietary technologies and products have b

'/>"/>

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading